Shanghai Synvida Biotechnology Co.,ltd.

This study tests a new drug, SV001, in 48 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either SV001 or a placeb…

This early-phase study tests the safety and how the body handles a new drug called SV003 in 60 healthy adults. Participants receive a single dose of either SV003 or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.

This early-stage study tests a new drug, SV001, in 53 healthy Chinese adults to see if it is safe and how the body processes it. The drug is being developed for idiopathic pulmonary fibrosis, a serious lung-scarring disease. This trial does not involve patients with the disease a…